Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors – and ...

Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP ...

However, he explained, “In this study, we demonstrated that there are in fact some genes without which a cancer cell cannot survive, making them excellent targets for CRISPR therapy. Since ...

撰文丨王聪编辑丨王多鱼排版丨水成文近年来，以 PD-1/PD-L1 抑制剂为代表的免疫检查点疗法彻底改变了癌症治疗格局，然而，相当一部分癌症患者对这些癌症免疫治疗“无动于衷”，癌细胞究竟用了什么“隐身术”来逃避免疫系统的追杀？近日，国际顶级学术期刊 ...

CRISPR gene editing targeted the SOX2 gene, eliminating 50% of tumors in mice. The therapy used lipid nanoparticles to deliver CRISPR directly into tumors. The study suggests CRISPR could be effective ...

From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 million upfront, building out another cancer-targeting approach.

We demonstrate that some genes are absolutely essential for cancer cell survival, making them excellent targets for CRISPR therapy,” said the research team in a press release. Although possible, ...

The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...